Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib.
Fadi G HaddadCedric NasnasKoji SasakiShilpa PaulGhayas C IssaCaitlin RauschElias JabbourHagop KantarjianPublished in: Clinical lymphoma, myeloma & leukemia (2024)